Indications and uses
Temporarily protects irritated areas. For the temporary relief of: local itching and discomfort in the perianal area pain or burning skin irritations
Temporarily protects irritated areas. For the temporary relief of: local itching and discomfort in the perianal area pain or burning skin irritations
Adults: When practical, cleanse the affected area with mild soap and warm water and rinse thoroughly. Gently dry by patting or blotting with toilet tissue or a soft cloth or air dry before application of this product. Apply externally to the affected area up to 6 times daily or after each bowel movement. Children under 12 years of age: consult a doctor.
Lanolin 15.7%
Menthol 0.44%
Petrolatum 24%
Zinc Oxide 20.6%
Active Ingredients Purpose
Lanolin 15.7%...........................Anorectal Protectant
Menthol 0.44%...........................Anorectal Analgesic
Petrolatum 24%........................Anorectal Protectant
Zinc Oxide 20.6%......Anorectal Protectant, Astringent
For external use only
* Certain persons can develop allergic reactions to ingredients in this product.
* Do not put this product into the rectum by using fingers or any mechanical device or applicator.
* Do not exceed the recommended daily dosage unless directed by a doctor.
* Avoid contact with eyes.
In case of accidental ingestion contact a physician or Poison Control Center immediately.
Adults: When practical, cleanse the affected area with mild soap and warm water and rinse thoroughly.
Gently dry by patting or blotting with toilet tissue or a soft cloth or air dry before application of this product.
Apply externally to the affected area up to 6 times daily or after each bowel movement.
Children under 12 years of age: consult a doctor.
calamine, chlorothymol, glycerin, phenol,
sodium bicarbonate, and thymol in a suitable ointment base
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1946481 | Calmoseptine 15.7 % / 0.44 % / 24 % / 20.6 % Topical Ointment | PSN | 14 |
| 1946476 | lanolin 15.7 % / menthol 0.44 % / petrolatum 24 % / zinc oxide 20.6 % Topical Ointment | PSN | 14 |
| 1946481 | lanolin 0.157 MG/MG / menthol 0.0044 MG/MG / petrolatum 0.24 MG/MG / zinc oxide 0.206 MG/MG Topical Ointment [Calmoseptine] | SBD | 14 |
| 1946476 | lanolin 0.157 MG/MG / menthol 0.0044 MG/MG / petrolatum 0.24 MG/MG / zinc oxide 0.206 MG/MG Topical Ointment | SCD | 14 |
| 1946481 | Calmoseptine Ointment (lanolin 0.157 MG/MG / menthol 0.0044 MG/MG / petrolatum 0.24 MG/MG / zinc oxide 0.206 MG/MG) Topical Ointment | SY | 14 |
| 1946481 | Calmoseptine OIntment (lanolin 15.7 % / menthol 0.44 % / petrolatum 24 % / zinc oxide 20.6 % ) Topical Ointment | SY | 14 |
| 1946476 | Lanolin 0.157 MG/MG / Menthol 0.0044 MG/MG / Petrolatum 0.24 MG/MG / ZNO 0.206 MG/MG Topical Ointment | SY | 14 |
| 1946481 | Lanolin 0.157 MG/MG / Menthol 0.0044 MG/MG / Petrolatum 0.24 MG/MG / ZNO 0.206 MG/MG Topical Ointment [Calmoseptine] | SY | 14 |
| 1946476 | lanolin 15.7 % / menthol 0.44 % / petrolatum 24 % / zinc oxide 20.6 % Topical Ointment | SY | 14 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0799-0001-02 | Calmoseptine | 71 g in 1 TUBE | OINTMENT | 71 | 14 | |
| 0799-0001-03 | Calmoseptine | 71 g in 1 JAR | OINTMENT | 71 | 14 | |
| 0799-0001-04 | Calmoseptine | 113 g in 1 TUBE | OINTMENT | 113 | 14 | |
| 0799-0001-05 | Calmoseptine | 3.5 g in 1 PACKET | OINTMENT | 3.5 | 14 | |
| 0799-0001-06 | Calmoseptine | 20 g in 1 TUBE | OINTMENT | 20 | 14 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0799-0001-02 | GM - Gram | 0799-0001 | 95b8e2fc-087a-4e01-83db-ce0dba8b6a81 | 1 | 2012-07-24 |
| 0799-0001-03 | GM - Gram | 0799-0001 | 6b232653-4859-4f99-b068-04502e33711f | 1 | 2017-10-13 |
| 0799-0001-04 | GM - Gram | 0799-0001 | e98285a3-d153-478e-9313-f028945ee9c3 | 1 | 2012-07-24 |
| 0799-0001-05 | GM - Gram | 0799-0001 | 0529cae0-8e6d-4662-b39b-f4c593dd85b8 | 1 | 2014-11-05 |
| 0799-0001-06 | GM - Gram | 0799-0001 | 86923745-4ac0-44a9-8331-e4693c473206 | 1 | 2023-06-06 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| MENTHOL | ACTIVE INGREDIENT | L7T10EIP3A | 8 | |
| ZINC OXIDE | ACTIVE INGREDIENT | SOI2LOH54Z | 8 | |
| MENTHOL | ACTIVE MOIETY | L7T10EIP3A | 8 | |
| ZINC OXIDE | ACTIVE MOIETY | SOI2LOH54Z | 8 | |
| Chlorothymol | INACTIVE INGREDIENT | LJ25TI0CVT | 8 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | 8 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 8 | |
| Lanolin | INACTIVE INGREDIENT | 7EV65EAW6H | 8 | |
| Phenol | INACTIVE INGREDIENT | 339NCG44TV | 8 | |
| Sodium Bicarbonate | INACTIVE INGREDIENT | 8MDF5V39QO | 8 | |
| Thymol | INACTIVE INGREDIENT | 3J50XA376E | 8 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0799-0001 | 0799-0001-02, 0799-0001-03, 0799-0001-04, 0799-0001-05, 0799-0001-06 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| FERRIC OXIDE RED | 1K09F3G675 | IACT |
| CHLOROTHYMOL | LJ25TI0CVT | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| PHENOL | 339NCG44TV | IACT |
| SODIUM BICARBONATE | 8MDF5V39QO | IACT |
| THYMOL | 3J50XA376E | IACT |
| LANOLIN | 7EV65EAW6H | ACTIB |
| MENTHOL | L7T10EIP3A | ACTIB |
| PETROLATUM | 4T6H12BN9U | ACTIB |
| ZINC OXIDE | SOI2LOH54Z | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Phenol | PHENOL | 339NCG44TV | INJECTION, SUSPENSION / SUBCUTANEOUS | 0.07 %w/v | ||
| Sodium Bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION / INTRAVENOUS | 812 mg | ||
| Sodium Bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 4 mg | ||
| Thymol | THYMOL | 3J50XA376E | LIQUID / RESPIRATORY (INHALATION) | 0.01 %w/w | ||
| Sodium Bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | TABLET, DELAYED RELEASE / ORAL | 30 mg | ||
| Phenol | PHENOL | 339NCG44TV | INJECTION, SOLUTION / INTRAMUSCULAR | 75 mg | ||
| Sodium Bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | TABLET, FILM COATED / ORAL | 86 mg | ||
| Phenol | PHENOL | 339NCG44TV | INJECTION / SUBCUTANEOUS | 48 mg | ||
| Phenol | PHENOL | 339NCG44TV | INJECTION / INTRASYNOVIAL | 0.5 %w/v | ||
| Phenol | PHENOL | 339NCG44TV | DOUCHE / VAGINAL | 0.14 %w/w | ||
| Sodium Bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION, SOLUTION / INTRAVENOUS | 52 mg | ||
| Phenol | PHENOL | 339NCG44TV | LIQUID / SUBCUTANEOUS | 0.5 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| Sodium Bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | TABLET, FILM COATED / ORAL | 86 mg | ||
| Phenol | PHENOL | 339NCG44TV | INJECTION / INTRAMUSCULAR | 48 mg | ||
| Phenol | PHENOL | 339NCG44TV | INJECTION / INTRASYNOVIAL | 0.5 %w/v | ||
| Sodium Bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | TABLET / ORAL | 1300 mg | ||
| Thymol | THYMOL | 3J50XA376E | LIQUID / RESPIRATORY (INHALATION) | 0.01 %w/w | ||
| Sodium Bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION / INTRATHECAL | 0.05 mg | ||
| Phenol | PHENOL | 339NCG44TV | INJECTION / INTRALESIONAL | 0.5 %w/v | ||
| Sodium Bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION / SUBCUTANEOUS | ADJ PH | ||
| Phenol | PHENOL | 339NCG44TV | INJECTION, SOLUTION / INTRAVENOUS | 75 mg | ||
| Phenol | PHENOL | 339NCG44TV | INJECTION / INTRA-ARTICULAR | 0.5 %w/v | ||
| Phenol | PHENOL | 339NCG44TV | INJECTION / INTRAMUSCULAR | 48 mg | ||
| Thymol | THYMOL | 3J50XA376E | POWDER, FOR SOLUTION / ORAL | NA | ||
| Sodium Bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 3219 mg | ||
| Sodium Bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION / SUBCUTANEOUS | ADJ PH | ||
| Sodium Bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION / SUBCUTANEOUS | ADJ PH | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| Sodium Bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION, SOLUTION / INTRAVENOUS | 52 mg | ||
| Sodium Bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | TABLET, COATED / ORAL | 10.6 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | LOTION / TOPICAL | NA | ||
| Phenol | PHENOL | 339NCG44TV | INJECTION, SOLUTION / INTRAVENOUS | 75 mg | ||
| Phenol | PHENOL | 339NCG44TV | LIQUID / SUBCUTANEOUS | 0.5 %w/v | ||
| Sodium Bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | TABLET, CHEWABLE / ORAL | 140 mg | ||
| Sodium Bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| Sodium Bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | TABLET, ORALLY DISINTEGRATING / ORAL | 107 mg | ||
| Phenol | PHENOL | 339NCG44TV | INJECTION / INTRAVENOUS | 48 mg | ||
| Sodium Bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| Phenol | PHENOL | 339NCG44TV | INJECTION / SUBCUTANEOUS | 48 mg | ||
| Sodium Bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | SOLUTION / ORAL | ADJ PH | ||
| Sodium Bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION / INTRAMUSCULAR | 175 mg | ||
| Phenol | PHENOL | 339NCG44TV | INJECTION / INTRAMUSCULAR | 48 mg | ||
| Thymol | THYMOL | 3J50XA376E | LIQUID / RESPIRATORY (INHALATION) | 0.01 %w/w | ||
| Thymol | THYMOL | 3J50XA376E | POWDER, FOR SOLUTION / ORAL | NA | ||
| Sodium Bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 160 mg | ||
| Sodium Bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION / SUBCUTANEOUS | ADJ PH | ||
| Phenol | PHENOL | 339NCG44TV | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 2 mg | ||
| Sodium Bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION / INTRATHECAL | 0.05 mg | ||
| Phenol | PHENOL | 339NCG44TV | INJECTION / SUBCUTANEOUS | 48 mg | ||
| Phenol | PHENOL | 339NCG44TV | DOUCHE / VAGINAL | 0.14 %w/w | ||
| Thymol | THYMOL | 3J50XA376E | POWDER, FOR SOLUTION / ORAL | NA | ||
| Sodium Bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| Phenol | PHENOL | 339NCG44TV | INJECTION, SOLUTION / SUBCUTANEOUS | 0.55 %w/v | ||
| Phenol | PHENOL | 339NCG44TV | INJECTION / INTRA-ARTICULAR | 0.5 %w/v | ||
| Sodium Bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION / INTRAVITREAL | 0.18 %w/v | ||
| Sodium Bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | FILM, SOLUBLE / ORAL | 2 mg | ||
| Phenol | PHENOL | 339NCG44TV | INJECTION / INTRAVENOUS | 48 mg | ||
| Phenol | PHENOL | 339NCG44TV | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 2 mg | ||
| Sodium Bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | LOZENGE / ORAL | 100 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Calmoseptine | ANORECTAL OINTMENT | Calmoseptine Inc. | ff9539ed-d9ae-401d-adbc-df8f1d751431 | 2025-01-13 | Warnings | 0799-0001-04 0799-0001-05 0799-0001-03 0799-0001-02 0799-0001-06 0799-0001 00799000104 00799000106 00799000103 00799000102 00799000105 2ba19ed3-445d-e95a-e063-6394a90abb3f ff9539ed-d9ae-401d-adbc-df8f1d751431 |
Adverse event summaries are temporarily unavailable. Other product information remains available.